SFDA CEO: Royal Address Reaffirms the Kingdom’s Pivotal Role in Advancing Peace and Sustaining Development

H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), commended the contents of the Royal Address delivered by HRH Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, on behalf of the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, at the opening of the third year of the Shura Council’s ninth session.

Dr. Aljadhey highlighted that the Royal Address underscored the Kingdom’s pivotal role in advancing peace, enhancing security and stability, and continuing its comprehensive development journey. The Royal Address also highlighted the progress achieved across various sectors, driven by the wise leadership’s commitment to national advancement and improving the quality of life.

The SFDA CEO emphasized that Saudi Vision 2030 serves as the guiding framework for government entities in achieving national objectives. He noted that the Vision places people at the heart of development and seeks to create a lasting impact while anticipating future needs. He further highlighted that the key performance indicators of Vision programs and strategies have achieved 93% of their targets.

Dr. Aljadhey prayed to Allah to protect the Custodian of the Two Holy Mosques and the Crown Prince, grant them continued health and well-being, and safeguard the Kingdom, preserving its security and stability and blessing it with long-lasting progress, stature, and prosperity.